It's not some flood gate being held back at that stage - phase 3 is simply where the majority of pharmaceutical companies fail.
MSB has one product they keep throwing at many different indications, doesn't mean it will work for all of them (or any).
It's not some flood gate being held back at that stage -...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
0.050(3.76%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.35 | $1.064M | 777.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58097 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 22157 | 8 |
View Market Depth
| Last trade - 10.17am 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |